Mon Dec 16 05:51:25 UTC 2024: **Wockhardt Share Price Soars 9%, Outperforming Healthcare Index**

**Mumbai, India** – Wockhardt’s share price experienced a significant surge today, climbing 9% to reach ₹1,503.0. This impressive gain contrasts with the overall performance of the BSE Healthcare index, which saw a slight dip of 0.1% to 44,017.9.

While Wockhardt led the gains in the sector, other notable performers included Sun Pharma Advanced Research (up 2.2%) and Glenmark Pharma (up 1.3%). Conversely, Caplin Point (down 1.3%) and Pfizer (down 1.1%) were among the top losers.

Over the past year, Wockhardt’s share price has increased by a remarkable 276.4%, rising from ₹399.3 to its current level. The BSE Healthcare index also saw substantial growth over the same period, rising 46.3%.

Despite the strong share price increase, Wockhardt reported a net profit of -₹160 million for the quarter ending September 2024, representing a 78.1% year-on-year improvement from a loss of ₹730 million. Net sales increased by 7.4% to ₹8,090 million. The company’s P/E ratio remains negative at -82.8.

The broader market indices, the BSE Sensex and NSE Nifty, experienced minor declines of 0.2% and 0.3%, respectively. JSW Steel and Bharti Airtel were among the top losers in the Sensex, while JSW Steel and Titan led the decline in the Nifty.

This report is based on data provided by Equitymaster, an independent equity research company operating since 1996. Equitymaster is registered with SEBI but is not an investment advisor. Investors are cautioned that market investments are subject to risk.

Read More